April 18, 2017. US Patent 9,624,549 issued about chemotherapy target identification

Apr 18, 2017   //   by Peter Rogan   //   News  //  Comments Off

US Patent 9,624,549 has been issued!
“Stable gene targets in breast cancer and use thereof for optimizing therapy. ” Peter K Rogan and Joan Knoll.    (link)

This technology is the basis of biochemically inspired chemotherapy prediction by machine learning (http://chemotherapy.cytognomix.com).

Download PDF

Comments are closed.